In contrast, BCR::ABL1 or tyrosine kinase fusions associated with myeloid/lymphoid neoplasms with eosinophilia, as well as JAK2, MPL, and CALR mutations, are used as exclusion criteria. This evidence concerns the gene ABL1 and Increased total eosinophil count.